By 2023, 37.97% of scientific publications in Canadian biotechnology involved international collaborations. This marks a significant rise from 25.76% in 2013. Between 2022 and 2023, the share increased by 2.49%, slightly higher than the 0.99% increase from 2021 to 2022. Over the past five years, the compound annual growth rate (CAGR) is 1.8%. The forecast predicts continued growth, with the share reaching 42.52% by 2028, reflecting a 9.32% growth rate over the five-year period.
Future trends to watch for include advancements in digital technologies facilitating cross-border collaboration, increased federal funding, and the impact of global health challenges necessitating international research efforts.
